Positive Interim Data Update: Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease.
Gene Therapy Company Reveals Promising Results From Huntington's Disease Clinical Trials
Gene Therapy Company Reveals Promising…
Gene Therapy Company Reveals Promising Results From Huntington's Disease Clinical Trials
Positive Interim Data Update: Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease.